動物醫療診斷的日本市場評估:各產品類型，各技術，各動物類型，各用途，各終端用戶，各地區，機會，預測(2018年度～2032年度)

日本獸醫醫療診斷市場規模預計將從 2024 財年的 2.5252 億美元增至 2032 財年的 5.1541 億美元，預計在 2025 財年至 2032 財年的預測期內複合年增長率為 9.33%。傳染病發病率的增加、政府措施的加強、使用先進技術的診斷解決方案的可用性以及寵物擁有量的增加支持了市場的成長。政府加強獸醫醫療部門的努力以及國內獸醫數量的增加正在擴大日本獸醫診斷市場的規模。截至 2023 年 6 月，日本獸醫協會 (JVMA) 透過 55 個協會代表日本各地的 28,000 名獸醫。

此外，由於獸醫提倡定期接種疫苗和健康檢查，人們對預防性獸醫保健的重視也推動了日本獸醫醫療診斷市場的成長。在引入能夠及早發現疾病的新診斷工具方面也取得了進展，同時也轉向預防性獸醫學。此外，對公共衛生和食品安全的日益關注也增加了日本對獸醫醫療診斷的需求。獸醫醫學診斷在確保牲畜健康和在加工供人類消費之前篩檢病原體方面發揮著重要作用。它還有助於監測傳染病，因為它們會對食品安全產生嚴重影響。因此，診斷測試對於防止病原體進入食品供應鏈並感染人類至關重要。

此外，分子診斷、即時檢測和快速檢測試劑盒等獸醫診斷領域的快速發展正在提高獸醫診斷解決方案的可及性和效率。因此，及時提供準確的結果增加了這些新技術在獸醫學中的採用。

本報告提供日本的動物醫療診斷市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 日本的動物醫療診斷市場預測(2018年度～2032年度)

• 市場規模的分析與預測
  • 金額
• 市場佔有率的分析與預測
  • 各產品
  • 各技術
  • 各動物類型
  • 各用途
  • 各終端用戶
  • 各地區
  • 市場佔有率分析:各企業(金額)(主要企業及其他 - 2024年度)
• 市場地圖分析(2024年度)
  • 各產品
  • 各技術
  • 各動物類型
  • 各用途
  • 各終端用戶
  • 各地區

第5章 供需分析

第6章 進口和出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

• 推動市場要素
• 市場課題

第12章 市場趨勢與發展

第13章 法規結構和革新

• 臨床試驗
• 法規當局的認證

第14章 專利形勢

第15章 案例研究

第16章 競爭情形

• 主要市場領導者的競爭矩陣
• 主要企業的SWOT分析
• 市場主要企業的形勢
  • IDEXX Laboratories, Inc.
  • Zoetis Services LLC
  • Virbac S.A.
  • Neogen Corporation
  • bioMerieux SA

第17章 策略性推薦

第18章 本公司相關資料，免責聲明

Japan veterinary diagnostics market is projected to witness a CAGR of 9.33% during the forecast period FY2025-FY2032, growing from USD 252.52 million in FY2024 to USD 515.41 million in FY2032. The market's growth is supported by rising outbreaks of infectious diseases, increasing government efforts, availability of technologically advanced diagnostic solutions, and rising adoption of pets. The government's efforts to strengthen the animal healthcare sector, coupled with the increasing number of veterinary professionals in the country, are boosting Japan's veterinary diagnostics market size. As of June 2023, the Japan Veterinary Medical Association (JVMA) represents 28,000 veterinarians across Japan through their 55 associations.

Furthermore, the growing emphasis on preventive healthcare for animals due to veterinary professionals advocating for regular vaccinations and check-ups is also bolstering the Japan veterinary diagnostics market growth. Novel diagnostic tools are also being introduced in the country to enable early disease detection, aligning with the shift toward preventive veterinary care. Moreover, the growing emphasis on public health and food safety is also augmenting the requirement for veterinary diagnostic products in Japan. Veterinary diagnostics play a crucial role in ensuring the livestock's health and screening pathogens before the animals are processed for food production. It also aids in monitoring infectious diseases, as these diseases can significantly impact the safety of food products. Diagnostic testing is thus essential to ensure that pathogens do not enter the food supply chain and get transmitted to humans.

Additionally, rapid advancements in the veterinary diagnostics sector, including molecular diagnostics, point-of-care testing, and rapid testing kits, are increasing the accessibility and efficiency of veterinary diagnostic solutions. Thus, providing more accurate results in a timely manner results in increased adoption of these novel technologies by veterinary practices.

Increasing Government Efforts Support Market Expansion

The rising effort of the Japanese government to bolster awareness about the importance of ensuring animal health is providing lucrative growth opportunities to the market. The government intends to disseminate awareness about animal welfare through educational activities in different educational institutions. Additionally, the Act on Welfare and Management of Animals recognizes that animals feel distress and pain and is clear on the expectations of organizations and animal owners. The Act undergoes a review process every five years to allow regular amendments to ensure animal welfare across Japan. Moreover, in the country, the Ministry of Agriculture, Forestry, and Fisheries is responsible for overseeing veterinary products under the Pharmaceutical and Medical Device Law to ensure the safety and quality of the products. The companies are required to receive approval from the Ministry after a comprehensive review by the National Veterinary Assay Laboratory (NVAL) and obtain licenses from approved marketing holders for distributing veterinary biologicals in Japan. The presence of such a regulatory framework ensures the provision of high-quality products in the country, boosting consumer confidence and positively influencing the market's expansion.

Technological Innovations Bolster Market Growth

The easy acceptance and availability of novel technologies in the country positively influences the market's expansion. Novel technologies, including enzyme-linked immunosorbent assay-based tests, are being launched in Japan. The non-invasive test is intended for usage during wellness checks on both older and younger dog breeds that are at a higher risk of developing cancer, including golden retrievers, boxers, beagles, and Bernese Mountain dogs. Additionally, in June 2024, the Japanese government officially allowed online medical consultations and established new guidelines. The new guidelines aim to improve the convenience of pet owners and aid veterinarians in taking up online services. Such approvals and launches are expected to enhance the quality of care available for animals and reduce the burden on veterinary professionals by allowing them to give remote patient consultations and make faster and more accurate decisions with the help of novel diagnostic kits.

Infectious Diseases Hold Major Market Share

The rising cases of infectious diseases in animals is another major factor augmenting the Japan veterinary diagnostics market's demand. Over the past few years, the outbreak of infectious diseases has significantly increased in Japan, propelling the requirement for veterinary diagnostic solutions. In 2024, the outbreak of bird flu occurred in a severe magnitude, prompting agencies to deliver swift responses and collaborate in an efficient manner to manage the growing threat. Such incidences are propelling the demand for veterinary diagnostics in the country to ensure early detection and diagnosis so that targeted treatment strategies can be deployed, and the outbreak of infectious diseases can be managed.

Companion Animals Account for a Significant Share of the Market

The rising adoption of companion animals in the country is propelling the demand for Japanese veterinary diagnostics. As per the estimates of the Japan Pet Food Association, in 2023, 397,000 dogs and 369,000 cats joined families in Japan. The growing adoption of companion animals can be attributed to the changing societal values, rising awareness about the different health benefits associated with the adoption of animals, and growing requirements for emotional connections and companionship. Companion animals are known to provide unconditional love and comfort to their owners in times of uncertainty and stress and form a strong emotional bond with them. Due to this, the owners are invested in their health and well-being and ensure that they are provided with proper medical care and attention. The owners also invest in regular health check-ups to ensure the well-being of their companion animals and provide them with necessary treatments, thus propelling the demand for veterinary diagnostic products.

Future Market Scenario (FY2025-FY2032F)

As per the Japan veterinary diagnostics market analysis, technological advancements in veterinary diagnostics are expected to provide lucrative growth opportunities to the market. The integration of advanced technologies, including machine learning and artificial intelligence, is expected to improve data analytics, aiding veterinary professionals in understanding patterns in animal health and predicting disease outbreaks.

With the expansion of molecular biology, the application of DNA-based diagnostics and genetic testing is expected to become more prevalent, facilitating disease identification at the molecular level and allowing veterinarians to provide accurate diagnoses and tailor treatment plans. This, in turn, will enhance treatment outcomes, improving patient satisfaction.

The growing adoption of pets in the country and increasing government initiatives to bolster the introduction and availability of high-quality veterinary diagnostic solutions in the country are also expected to provide lucrative growth opportunities to the Japan veterinary diagnostics market.

Key Players Landscape and Outlook

Various major market players are significantly investing in mergers and acquisitions to broaden their product portfolio and expand their footprint in the country. In March 2024, Virbac S.A. acquired Sasaeah Pharmaceutical Co., Ltd. to expand its global footprint and cement its position in the animal healthcare industry in Japan. The deal was worth approximately USD 309 million and is expected to allow Virbac to expand its share in the Japanese market with the help of Sasaeah's diverse product portfolio that caters to both companion and farm animals. Moreover, the deal also grants the former access to many pharmaceutical products across major species. The acquisition also aligns with Virbac's vision for 2030 and long-term goals for geographical expansion and improving animal health in Japan. This acquisition represents a significant milestone in Virbac's commitment to innovation, expansion, and growth trajectory in the Japanese animal health arena.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Veterinary Diagnostics Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Consumables
    • 4.2.1.2. Instruments
  • 4.2.2. By Technology
    • 4.2.2.1. Immunodiagnostics
      • 4.2.2.1.1. ELISA
      • 4.2.2.1.2. Radioimmunoassays
      • 4.2.2.1.3. Lateral flow Assays
      • 4.2.2.1.4. Others
    • 4.2.2.2. Molecular Diagnostics
      • 4.2.2.2.1. PCR Tests
      • 4.2.2.2.2. Microarrays
      • 4.2.2.2.3. Nucleic Acid Sequencing
    • 4.2.2.3. Clinical Biochemistry
      • 4.2.2.3.1. Clinical Chemistry Analysis
      • 4.2.2.3.2. Glucose Monitoring
      • 4.2.2.3.3. Blood Gas and Electrolyte Analysis
    • 4.2.2.4. Hematology
    • 4.2.2.5. Others
  • 4.2.3. By Animal Type
    • 4.2.3.1. Companion Animals
      • 4.2.3.1.1. Dogs
      • 4.2.3.1.2. Cats
      • 4.2.3.1.3. Horses
      • 4.2.3.1.4. Others
    • 4.2.3.2. Livestock
      • 4.2.3.2.1. Cattle
      • 4.2.3.2.2. Pigs
      • 4.2.3.2.3. Poultry
      • 4.2.3.2.4. Others
  • 4.2.4. By Application
    • 4.2.4.1. Infectious Diseases
      • 4.2.4.1.1. Bacterial Infections
      • 4.2.4.1.2. Parasitic Infections
      • 4.2.4.1.3. Viral Infections
    • 4.2.4.2. Endocrinology
    • 4.2.4.3. Oncology
    • 4.2.4.4. Cardiology
    • 4.2.4.5. Others
  • 4.2.5. By End-user
    • 4.2.5.1. Veterinary Hospitals and Clinics
    • 4.2.5.2. Veterinary Reference Laboratories
  • 4.2.6. By Region
    • 4.2.6.1. North [Hokkaido and Tohoku]
    • 4.2.6.2. Central [Kanto and Chubu]
    • 4.2.6.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.7. By Company Market Share Analysis (Top Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Technology
  • 4.3.3. By Animal Type
  • 4.3.4. By Application
  • 4.3.5. By End-user
  • 4.3.6. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Clinical Trials
• 13.2. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top Market Leaders
• 16.2. SWOT Analysis for Top Players
• 16.3. Key Players Landscape for Top Market Players
  • 16.3.1. IDEXX Laboratories, Inc.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Zoetis Services LLC
  • 16.3.3. Virbac S.A.
  • 16.3.4. Neogen Corporation
  • 16.3.5. bioMerieux SA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Veterinary Diagnostics Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Veterinary Diagnostics Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Veterinary Diagnostics Market Share (%), By Technology, FY2018-FY2032F
• Figure 4. Japan Veterinary Diagnostics Market Share (%), By Animal Type, FY2018-FY2032F
• Figure 5. Japan Veterinary Diagnostics Market Share (%), By Application, FY2018-FY2032F
• Figure 6. Japan Veterinary Diagnostics Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. Japan Veterinary Diagnostics Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Technology Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Animal Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024